News | Magnetic Resonance Imaging (MRI)

Miami Cardiac & Vascular Institute announced the implementation of Philips’ Ingenia Ambition 1.5T MR, the world’s first magnetic resonance imaging (MRI) system to enable helium-free operations. The technology offers cutting-edge imaging techniques that deliver high-quality images faster while providing an improved, more comfortable experience for patients, according to Philips.

Time May 17, 2019
Home
Feature | Artificial Intelligence | Inga Shugalo

With its increasing role in medical imaging, artificial intelligence (AI) gradually is becoming a go-to technology for ...

Time May 17, 2019
Home
News | Radiopharmaceuticals and Tracers

Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in patients suffering from coronary artery disease using the company's new one-vial Oncardia (ethylenedicysteine-glucosamine) kits. The 60-patient trial study is being conducted in the U.S.

Time May 17, 2019
Home
Feature | Information Technology | Carol Amick

According to the U.S. Department of Health and Human Services (HHS), about 70 percent of organizations are not compliant ...

Time May 17, 2019
Home
Webinar | Enterprise Imaging

The webinar "Realizing the Value of Enterprise Imaging: 5 Key Strategies for Success" will outline how to improve ...

Time May 16, 2019
Home
Videos | Advanced Visualization

This is an example of how virtual reality is being used in neuro-radiology to better evaluate patients using advanced ...

Time May 16, 2019
Home
News | Mammography

High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US) correlate or magnetic resonance imaging (MRI) enhancement suggests follow-up rather than biopsy may be safely performed, according to a new study. The study was presented at the American Roentgen Ray Society (ARRS) 2019 Annual Meeting, May 5-10 in Honolulu.High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US) correlate or magnetic resonance imaging (MRI) enhancement suggests follow-up rather than biopsy may be safely performed, according to a new study. The study was presented at the American Roentgen Ray Society (ARRS) 2019 Annual Meeting, May 5-10 in Honolulu.

Time May 15, 2019
Home
Technology | Ultrasound Imaging

Clarius Mobile Health released a telemedicine solution called Clarius Live. The simple-to-use feature allows any Clarius user to easily request real-time assistance while performing an ultrasound exam with their Clarius Ultrasound Scanner. The feature is fully integrated into the current version of the app and is activated with a single tap on the screen, which opens a prompt to enter an email address or phone number to connect with anyone around the world.

Time May 15, 2019
Home
Technology | Artificial Intelligence

Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA) clearance for an additional product in its expanding suite of AI-based workflow orchestration solutions. The clearance is for Aidoc's Pulmonary Embolism (PE) solution that works with radiologists to flag and triage PE cases in chest computed tomography (CT) scans. The approval comes just weeks after Aidoc closed a $27 million funding round, bringing its total funding to $40 million.

Time May 15, 2019
Home
News | Radiation Therapy

Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime. However, in a new study from UBC Okanagan and Duke University, researchers have developed a system they say may improve the ability to maximize radiation doses to cancer tissues while minimizing exposure to healthy ones.

Time May 14, 2019
Home
Technology | Patient Engagement

Icon plc announced the release of its web-based clinical trial patient engagement platform, to provide patients with study-specific information and connectivity with the nearest investigative site. The solution supplements patient recruitment outreach by sites and increases visibility of potential study participants for sponsors and sites.

Time May 14, 2019
Home
News | Radiopharmaceuticals and Tracers

Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first commercial production of Axumin in Belgium occurred recently, with the first Belgian patients being dosed. This follows the first administration of Axumin in Luxembourg earlier this year. Axumin is the first and only positron emission tomography (PET) imaging agent approved in the European Union for use in men with suspected recurrent prostate cancer. Axumin is commercially available in Belgium, Luxembourg, Italy, France, Norway, the Czech Republic, The Netherlands, United Kingdom and Austria, with further European countries set to follow soon.

Time May 13, 2019
Home
News | Artificial Intelligence

NVIDIA and King’s College London announced they are partnering to build an artificial intelligence (AI) platform that will in the near future allow specialists in the U.K.’s National Health Service (NHS) to train computers to automate the most time-consuming part of radiology interpretation.

Time May 13, 2019
Home
Sponsored Content | Videos | Radiation Oncology

At ASTRO 2018, Accuray showcased new patient-first innovations, including motion synchronization on Radixact, and the ...

Time May 13, 2019
Home
Technology | Artificial Intelligence

Zebra Medical Vision has received U.S. Food and Drug Administration (FDA) 510(k) clearance for HealthPNX, an artificial intelligence (AI) alert for pneumothorax (PNX) based on chest X-rays.

Time May 13, 2019
Home
News | Magnetic Resonance Imaging (MRI)

Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a magnetic resonance imaging (MRI) ablation center for treating cardiac arrhythmias.

Time May 13, 2019
Home
Feature | Artificial Intelligence

The integration of artificial intelligence (AI) into medicine has by far been the hottest topic at nearly all medical ...

Time May 13, 2019
Home
News | Radiation Therapy

Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy after chemotherapy, even when all traces of the cancer appear to have gone. These findings are according to late-breaking results presented at the European Society for Radiotherapy and Oncology (ESTRO) 38 conference, April 26-30 in Milan, Italy.

Time May 10, 2019
Home
News | Proton Therapy

IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain and Telemis aimed at accelerating installation, optimizing service and improving clinical operations for proton therapy.

Time May 10, 2019
Home
News | Radiopharmaceuticals and Tracers | Jeff Zagoudis, Associate Editor

Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S. Department of Energy (DOE) Under Secretary for Nuclear Security and Administrator of the National Nuclear Security Administration (NNSA) Lisa Gordon-Hagerty, Lantheus Medical Imaging President and CEO Mary Heino and Janesville City Manager Mark Freitag joined Shine founder and CEO, Greg Piefer, and the Shine team to celebrate the milestone.

Time May 10, 2019
Home
Subscribe Now